Drugs / MMF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00350181 | Aug 2006 → Aug 2007 | acute graft versus host disease, leukemia, non-Hodgkin lymphoma | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00350181 ↗ |
| Route | Intravenous | “Immunosuppressant given through IV on day 0 at 15 mg/kg twice daily ≥ 2hr after the completion for the donor cell infusion” NCT00350181 ↗ |